Insight Report 2 minutes PremiumRite Aid (RAD) 2Q17 RESULTS: ACQUISITION ON TRACK TO CLOSE IN 2H16 Coresight Research September 23, 2016 Executive Summary Rite Aid reported adjusted EPS of $0.03, beating the $0.02 consensus estimate and up from last year’s $0.02. Businesses that contributed to the positive results included its EnvisionRX PBM, and its strong front-end segment. There was some improvement in prescription drug costs, which was offset by challenging reimbursement rates. The company continues to believe that the announced acquisition of Rite Aid by Walgreens will close in the second half of 2016. This report is for paying subscribers only. Already a paying subscriber? Please log in to see the entire report.If you wish to learn more about our subscription plans and become a paying subscriber, click here. This document was generated for Other research you may be interested in: Healthcare—2024 Shopper Outlook: Insights Presented at the Drug Store News Industry Issues Summit 2023Shoptalk Europe 2023 Day Three: Retail Media and Technology Take Center StageWeekly US and UK Store Openings and Closures Tracker 2023, Week 51: Previewing Plans for 2024—Dollar General (US) and Asda (UK) To Lead Store OpeningsWeekly US and UK Store Openings and Closures Tracker 2023, Week 10: US Openings Cross 3,500